High Priority Immunology Grants
Deadline: February 5, 2016
The goal of this Funding Opportunity Announcement (FOA) is to augment the maintenance and growth of the NIAID portfolio of investigator-initiated R01 grants in fundamental immunology. It seeks to address a decline in NIAID immunology R01 applications and awards that has occurred in the past several fiscal years. Basic immunology and basic immune mechanisms involved in host defense and immune-mediated diseases are of high programmatic interest in this FOA.
Neurobiology of Migraine
Deadline: February 5, 2016
National Institutes of Health (NIH) participating Institutes and Centers invite applications from institutions/organizations to perform innovative research that will elucidate the mechanisms underlying migraine, expand our current knowledge of the role of genetic, physiological, biopsychosocial, and environmental influences in migraine susceptibility and progression, and explore new therapeutic targets and therapies for acute migraine management and longer term prevention. This program will use the NIH Research Project (R01) award mechanism.
Integrative Neuroscience Initiative on Alcoholism (INIA) Consor
Deadline: February 10, 2016
NIAAA seeks integrated, multidisciplinary, collaborative research projects studying neuronal mechanisms of excessive alcohol intake associated with alcohol dependence. One focus of the initiative will be to examine brain immune signaling mechanisms promoting and controlling excessive alcohol consumption. A second focus will be to examine enduring consequences of stress challenges on adaptations in brain circuitry leading to excessive drinking and to altered stress responsiveness.
NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics
Deadline: February 11, 2016
The NINDS Cooperative Research to Enable and Advance Translational Enterprises for Biotechnology Products and Biologics (CREATE Bio) program is dedicated to biotechnology product- and biologics- based therapies, which broadly include modalities such as peptides, proteins, oligonucleotides, gene therapies, and cell therapies. The program includes two tracks: the Discovery Track supports lead optimization in order to obtain a candidate appropriate for entering the Development Track, and the Development Track supports IND-enabling studies for the candidate, as well as early-phase clinical trials.
Young Investigator Grant for Probiotics Research
Deadline: February 12, 2016
The program objectives are: to stimulate innovative research relevant to the field of gastrointestinal microbiota in the United States; to impact academic and career development of young investigators in the United States and attract them into the field of probiotics and gastrointestinal microbiota; and to provide preliminary data for future funding from NIH and other funding sources.
Foundation for Prader-Willi Research
Deadline: February 15, 2016
The Foundation for Prader-Willi Research (FPWR) supports research to advance the understanding and treatment of Prader-Willi syndrome (PWS).
Biomechanics and Mechanobiology
Deadline: February 16, 2016
The BMMB Program supports fundamental research in biomechanics and mechanobiology. An emphasis is placed on multiscale mechanics approaches in the study of organisms that integrate across molecular, cell, tissue, and organ domains. The influence of in vivo mechanical forces on cell and matrix biology in the histomorphogenesis, maintenance, regeneration, and aging of tissues is an important concern. In addition, the relationships between mechanical behavior and extracellular matrix composition and organization are of interest. Funded projects may include theoretical, computational, and experimental approaches. The program encourages the consideration of diverse living tissues as smart materials that are self-designing.
Exploratory/Developmental Bioengineering Research Grants
Deadline: February 16, 2016
NIH and it’s participating Institutes and Centers invite applications which establish the feasibility of technologies, techniques or methods that: 1) explore a new multidisciplinary approach to a biomedical challenge; 2) are high-risk but have high impact; and 3) develop data that may lead to significant future research. An EBRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research and is appropriate for evaluating unproven approaches for which there is minimal or no preliminary data.
Molecular Transducers of Physical Activity Bioinformatics Center
Deadline: February 18, 2016
The overall goals of the Bioinformatics Center are to provide a database and associated tools for storage and integration of clinical physiological and metabolic data along with multiple types of chemical analysis data derived through metabolomics, proteomics, genomics, transcriptomics, or similar technologies.